The Editor in Chief of Clinical Medical Insights: Oncology, Dr William C S Cho, has awarded an endorsement to Moving on up: Second-line agents as initial treatment for newly-diagnosed patients with chronic phase CML
In the endorsement the Editor in Chief writes:
The review is concise and covers a broad aspect of initial treatment of newly-diagnosed patients with chronic phase CML with tyrosine kinase inhibitors.
To read more visit the article now: Moving on up: Second-line agents as initial treatment for newly-diagnosed patients with chronic phase CML
Posts
